SCM
MRTX
Silverarc Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 95 |
|
|
2023
Q4 | – | Sell |
-200,000
| Closed | -$8.71M | – | 86 |
|
|
2023
Q3 | $8.71M | Buy |
200,000
+108,787
| +119% | +$4.74M | 2.64% | 7 |
|
|
2023
Q2 | $3.3M | Buy |
+91,213
| New | +$3.3M | 1.02% | 30 |
|
|
2022
Q4 | – | Sell |
-10,220
| Closed | -$714K | – | 96 |
|
|
2022
Q3 | $714K | Sell |
10,220
-26,183
| -72% | -$1.83M | 0.24% | 56 |
|
|
2022
Q2 | $2.44M | Sell |
36,403
-9,719
| -21% | -$653K | 0.75% | 28 |
|
|
2022
Q1 | $3.79K | Sell |
46,122
-14,635
| -24% | -$1.2K | 1.57% | 15 |
|
|
2021
Q4 | $8.91M | Buy |
60,757
+14,816
| +32% | +$2.17M | 3.61% | 6 |
|
|
2021
Q3 | $8.13M | Buy |
45,941
+8,188
| +22% | +$1.45M | 4.59% | 3 |
|
|
2021
Q2 | $6.1K | Buy |
37,753
+32,753
| +655% | +$5.29K | 2.72% | 4 |
|
|
2021
Q1 | $857K | Sell |
5,000
-15,000
| -75% | -$2.57M | 0.47% | 55 |
|
|
2020
Q4 | $4.39M | Buy |
+20,000
| New | +$4.39M | 2.55% | 10 |
|